US2019264169A1PendingUtilityA1
Compositions and methods for recovery of stranded gas and oil
Est. expiryJan 16, 2034(~7.5 yrs left)· nominal 20-yr term from priority
Inventors:Howard Lam-Ho FongJohn H. GrateLuan NguyenJoshua SilvermanLisa Marie NewmanLorraine GiverDrew D. Regitsky
C09K 2208/20C09K 8/532C10G 32/00C12N 9/0051C12N 15/74C10L 1/08C10G 2400/04B01D 2251/95B01D 2256/245C12N 9/0069C10G 2300/1025C10G 2300/202C10G 2400/08C10G 2400/02A23N 17/00B01D 53/85B01D 2258/05B01D 2256/24B01D 2257/304C10L 1/06C10L 3/102C10L 1/04C10L 2290/544C12P 7/6463Y02P30/20C10G 3/00A23K 10/10C12N 1/20C12P 13/12B01D 53/526B01D 2257/504B01D 2252/204Y02A50/2359C12R 1/01C12R 2001/01C12N 1/205Y02P20/59Y02C20/40Y02A50/20Y02P20/151
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides compositions and methods for using recombinant C1 metabolizing microorganisms capable of metabolizing sulfur containing compounds and other contaminants to biologically convert sour or acidic natural gas into high-value molecules, and to allow recovery of stranded oil.
Claims
exact text as granted — not AI-modified1 .- 125 . (canceled)
126 . A recombinant methanotrophic or methylotrophic bacterium, comprising:
(a) a first heterologous nucleic acid molecule encoding a polypeptide capable of metabolizing an S substrate selected from:
(i) a hydrogen sulfide:NADP + oxidoreductase, hydrogen sulfide:ferredoxin oxidoreductase, sulfide: flavocytochrome-c oxidoreductase, sulfide: quinone oxidoreductase, sulfur dioxygenase, sulfite oxidase, or any combination thereof;
(ii) a hydrogen sulfide:NADP + oxidoreductase, sulfite oxidase, or both;
(iii) a hydrogen sulfide:ferredoxin oxidoreductase, sulfite oxidase, or both;
(iv) a sulfide:flavocytochrome-c oxidoreductase, sulfite oxidase, or both;
(v) a sulfide:quinone oxidoreductase, sulfite oxidase, or both; and
(vi) a hydrogen sulfide:NADP + oxidoreductase, hydrogen sulfide:ferredoxin oxidoreductase, sulfide: flavocytochrome-c oxidoreductase, or sulfide: quinone oxidoreductase, wherein endogenous sulfite oxidase activity of the bacterium is increased; and
(b) a second heterologous nucleic acid molecule encoding a cysteine biosynthesis pathway, homocysteine biosynthesis pathway, or a methionine biosynthesis pathway, wherein:
(i) the cysteine biosynthesis pathway comprises a cysteine synthase;
(ii) the homocysteine biosynthesis pathway comprises an O-acetylhomoserine sulfhydrylase; and
(iii) the methionine biosynthesis pathway comprises an O-acetylhomoserine sulfhydrylase and a methionine synthase or a homocysteine methyltransferase;
wherein the recombinant methanotrophic or methylotrophic bacterium is capable of converting a feedstock comprising the S substrate and a C 1 substrate into the sulfur-containing amino acid and is capable of oxidizing or assimilating an increased amount of the S substrate as compared to wild-type methanotrophic or methylotrophic bacterium.
127 . The recombinant methanotrophic or methylotrophic bacterium according to claim 126 , wherein the methanotrophic or methylotrophic bacterium is a methanotrophic bacterium.
128 . The recombinant methanotrophic or methylotrophic bacterium according to claim 127 , wherein the methanotrophic bacterium is an obligate methanotrophic bacterium.
129 . The recombinant methanotrophic or methylotrophic bacterium according to claim 127 , wherein the methanotrophic bacterium is Methylococcus capsulatus Bath, Methylomonas 16a, Methylosinus trichosporium OB3b, Methylosinus sporium, Methylocystis parvus, Methylomonas methanica, Methylomonas albus, Methylobacter capsulatus, Methylobacterium organophilum, Methylomonas sp. AJ-3670, Methylocella silvestris, Methylocella palustris, Methylocella tundrae, Methylocystis daltona strain SB2, Methylocystis bryophila, Methylocapsa aurea KYG, Methylacidiphilum infernorum, or Methylomicrobium alcaliphilum.
130 . The recombinant methanotrophic or methylotrophic bacterium according to claim 127 , wherein the methanotrophic bacterium is Methylococcus capsulatus Bath, Methylosinus trichosporium OB3b, Methylomonas sp. 16a, Methylomicrobium alcaliphilum, or a high growth variant thereof.
131 . The recombinant methanotrophic or methylotrophic bacterium according to claim 127 , wherein the recombinant methanotrophic bacterium is in a culture further comprising a heterologous bacterium.
132 . The recombinant methanotrophic or methylotrophic bacterium according to claim 126 , wherein the methanotrophic or methylotrophic bacterium is a methylotrophic bacterium.
133 . The recombinant methanotrophic or methylotrophic bacterium according to claim 132 , wherein the methylotrophic bacterium is Methylobacterium extorquens, Methylobacterium radiotolerans, Methylobacterium populi, Methylobacterium chloromethanicum, or Methylobacterium nodulans.
134 . The recombinant methanotrophic or methylotrophic bacterium according to claim 126 , wherein the polypeptide capable of metabolizing the S substrate:
(a) is encoded by a nucleic acid comprising the polynucleotide sequence as set forth in any one of SEQ ID NOS.:21-54; (b) comprises the amino acid sequence as set forth in any one of SEQ ID NOS.:55-88; (c) is a sulfur oxygenase; or (d) is a sulfur oxygenase having an amino acid sequence that is at least 75% identical to the sequence set forth in Genbank Accession No. AAK58572.1 or ABN04222.1, or a functional fragment thereof.
135 . The recombinant methanotrophic or methylotrophic bacterium according to claim 126 , wherein the second heterologous nucleic acid molecule encodes the cysteine biosynthesis pathway comprising the cysteine synthase.
136 . The recombinant methanotrophic or methylotrophic bacterium according to claim 126 , wherein the second heterologous nucleic acid molecule encodes the homocysteine biosynthesis pathway comprising the O-acetylhomoserine sulfhydrylase.
137 . The recombinant methanotrophic or methylotrophic bacterium according to claim 126 , wherein the second heterologous nucleic acid molecule encodes the methionine biosynthesis pathway comprising the O-acetylhomoserine sulfhydrylase and the methionine synthase or the homocysteine methyltransferase.
138 . A method for producing a sulfur-containing amino acid from a tainted gas, the method comprising culturing a recombinant methanotrophic bacterium or methylotrophic bacterium according to claim 126 with a tainted gas feedstock,
wherein the tainted gas feedstock comprises methane and an S substrate;
wherein the methanotrophic bacterium or methylotrophic bacterium assimilates and oxidizes the methane and the S substrate, and converts the S substrate into the sulfur-containing amino acid selected from cysteine, homocysteine, or methionine.
139 . The method according to claim 138 , wherein the tainted gas feedstock comprises natural gas, unconventional natural gas, casinghead gas, wellhead condensate, or any combination thereof.
140 . The method according to claim 138 , wherein the recombinant methanotrophic bacterium or methylotrophic bacterium is a methanotrophic bacterium selected from Methylococcus capsulatus Bath, Methylosinus trichosporium OB3b, Methylomonas sp. 16a, Methylomicrobium alcaliphilum, or a high growth variant thereof.
141 . A system for producing a sulfur-containing amino acid from a tainted gas, comprising:
a source of tainted gas comprising methane and an S substrate; a bioreactor comprising a recombinant methanotrophic bacterium or methylotrophic bacterium according to claim 126 ; wherein the recombinant methanotrophic bacterium or methylotrophic bacterium cultured in the bioreactor converts the methane and the S substrate of the tainted gas into a sulfur-containing amino acid selected from cysteine, homocysteine, or methionine.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.